日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prophylactic protocol for cerebral infarction after left upper lobectomy and prospective analysis of pulmonary vein stump thrombosis

左上肺叶切除术后脑梗死的预防方案及肺静脉残端血栓形成的前瞻性分析

Matsumoto, Akira; Yutaka, Yojiro; Sakanoue, Ichiro; Kayawake, Hidenao; Sumitomo, Ryota; Nishikawa, Shigeto; Tanaka, Satona; Nakajima, Daisuke; Menju, Toshi; Muramatsu, Yuriko; Hidaka, Yu; Date, Hiroshi

Novel TEAD1 Inhibitor VT103 Enhances Dabrafenib Efficacy in BRAF V600E Mutated Lung Adenocarcinoma via Survivin Downregulation

新型TEAD1抑制剂VT103通过下调Survivin增强达拉非尼在BRAF V600E突变肺腺癌中的疗效

Hosoya, Kazutaka; Ozasa, Hiroaki; Yoshida, Hironori; Ajimizu, Hitomi; Tsuji, Takahiro; Yamazoe, Masatoshi; Ogimoto, Tatsuya; Hashimoto, Kentaro; Funazo Yamamoto, Tomoko; Suminaga, Keiichiro; Shima, Yusuke; Yoshida, Hiroshi; Nomizo, Takashi; Ito, Hiroaki; Terada, Kazuhiro; Nishikawa, Shigeto; Menju, Toshi; Yoshizawa, Akihiko; Date, Hiroshi; Hirai, Toyohiro

The novel compound PICCS improves cell viability during cold storage and reduces pulmonary ischemia-reperfusion injury in a rat model.

新型化合物PICCS可提高细胞在冷藏期间的存活率,并减少大鼠模型中的肺缺血再灌注损伤

Yokoyama Yuhei, Toyomoto Masayasu, Tanaka Nobuo, Tanaka Satona, Nishikawa Shigeto, Kayawake Hidenao, Morimura Yuki, Oda Hiromi, Yamauchi Momono, Yamamoto Makoto, Chen-Yoshikawa Toyofumi F, Hagiwara Masatoshi, Date Hiroshi

Work-in-progress report: a prospective, multi-institutional observational study on intraoperative lymph node dissection for thymic epithelial malignancies with radiologically invasive features

进行中的工作报告:一项前瞻性、多中心观察性研究,探讨胸腺上皮恶性肿瘤(具有放射学侵袭性特征)术中淋巴结清扫术。

Hamaji, Masatsugu; Nishikawa, Shigeto; Koyasu, Sho; Yutaka, Yojiro; Kojima, Fumitsugu; Nakanishi, Takao; Kono, Tomoya; Yamada, Yoshito; Hijiya, Kyoko; Ohata, Keiji; Kikuchi, Ryutaro; Miyamoto, Ei; Nakagawa, Tatsuo; Omasa, Mitsugu; Miyahara, Ryo; Bando, Toru; Date, Hiroshi

Pathological Features and Differential Efficacy of Cisplatin-Based Adjuvant Chemotherapy in Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations

表皮生长因子受体突变肺癌的病理特征及顺铂辅助化疗的差异疗效

Kabuto, Takafumi; Menju, Toshi; Nishikawa, Shigeto; Terada, Kazuhiro; Yoshizawa, Akihiko; Date, Hiroshi

Drugs Targeting p53 Mutations with FDA Approval and in Clinical Trials

已获FDA批准并正在进行临床试验的靶向p53突变的药物

Nishikawa, Shigeto; Iwakuma, Tomoo

DNAJA1- and conformational mutant p53-dependent inhibition of cancer cell migration by a novel compound identified through a virtual screen

通过虚拟筛选发现的一种新型化合物,可通过抑制DNAJA1和构象突变型p53来抑制癌细胞迁移。

Nishikawa, Shigeto; Kaida, Atsushi; Parrales, Alejandro; Ranjan, Atul; Alalem, Mohamed; Ren, Hongyi; Schoenen, Frank J; Johnson, David K; Iwakuma, Tomoo

Osteoclasts adapt to physioxia perturbation through DNA demethylation

破骨细胞通过 DNA 去甲基化适应生理氧扰动

Keizo Nishikawa, Shigeto Seno, Toshitada Yoshihara, Ayako Narazaki, Yuki Sugiura, Reito Shimizu, Junichi Kikuta, Reiko Sakaguchi, Norio Suzuki, Norihiko Takeda, Hiroaki Semba, Masamichi Yamamoto, Daisuke Okuzaki, Daisuke Motooka, Yasuhiro Kobayashi, Makoto Suematsu, Haruhiko Koseki, Hideo Matsuda, M

Prognostic Significance of Phosphorylated Fyn in Patients with Lung Adenocarcinoma after Lung Resection.

肺切除术后肺腺癌患者磷酸化Fyn的预后意义

Nishikawa Shigeto, Menju Toshi, Takahashi Koji, Miyata Ryo, Sonobe Makoto, Yoshizawa Akihiko, Date Hiroshi

Successful treatment of late onset empyema after extrapleural pneumonectomy: A case report

成功治疗胸膜外全肺切除术后迟发性脓胸:病例报告

Nishikawa, Shigeto; Tamari, Shigeyuki; Okita, Kenji; Chihara, Koji